JGTTX
Price
$32.18
Change
+$0.09 (+0.28%)
Updated
Apr 17 closing price
Net Assets
17.88B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

JGTTX vs VIGRX

Header iconJGTTX vs VIGRX Comparison
Open Charts JGTTX vs VIGRXBanner chart's image
JPMorgan Growth Advantage R3
Price$32.18
Change+$0.09 (+0.28%)
VolumeN/A
Net Assets17.88B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
JGTTX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGTTX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGTTX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. JGTTX (17.9B). VIGRX pays higher dividends than JGTTX: VIGRX (0.39) vs JGTTX (0.00). JGTTX was incepted earlier than VIGRX: JGTTX (8 years) vs VIGRX (32 years). JGTTX (1.09) is less costly to investors than VIGRX (0.17). JGTTX is a more actively managed with annual turnover of: 28.00 vs. VIGRX (5.00). JGTTX has a lower initial minimum investment than VIGRX: JGTTX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. JGTTX (-3.86). VIGRX return over 5 years is better than : 99.21 vs. JGTTX (48.77).
JGTTXVIGRXJGTTX / VIGRX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.090.17641%
Fund Existence8 years32 years-
Gain YTD-14.858-14.326104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.9B261B7%
Annual Yield % from dividends0.000.39-
Returns for 1 year-3.866.01-64%
Returns for 3 years17.3730.3357%
Returns for 5 years48.7799.2149%
Returns for 10 yearsN/A223.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics